【NEXGRAM 0096 交流专区】（前名 NEXTNAT）

icy97

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD (NEXGRAM OR THE COMPANY) CONDITIONAL OFFTAKE AND PURCHASE AGREEMENT ENTERED INTO BETWEEN NEXGRAM BIOMEDIC SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING PERSONAL PROTECTION EQUIPMENT TO INDONESIA
The Board of Directors of Nexgram is pleased to announce that Nexgram Biomedic Sdn Bhd. (“NBSB”), a wholly-owned sub-subsidiary of the Company entered into a Conditional Offtake and Purchase Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) on 22 July 2020 to sell to MAPU for the latter to promote, market and distribute personal protection equipment (“PPE”) includes gown known as AAMI Isolation Gown and medical glove product known as K-Gloves Nitrile Examination Gloves-powder free in Indonesia, as per the terms and condition of the Agreement. Please refer to the attachment for details of the announcement. This announcement is dated 23 July 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3071382

Attachments NHB-COPA with MAPU .pdf

icy97

NEXGRAM HOLDINGS BERHAD

Particulars of substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	24 Jul 2020	31,500,000	Disposed	Direct Interest
	Name of registered holder	OZURA FIRSTLOGIX SDN BHD
	Address of registered holder	1-47, Jalan SP2 Taman Segar Perdana 43200 Cheras Selangor
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of Shares
Nature of interest	Direct Interest
Direct (units)	258,500,000
Direct (%)	10.959
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	258,500,000
Date of notice	27 Jul 2020
Date notice received by Listed Issuer	27 Jul 2020

icy97

NEXGRAM HOLDINGS BERHAD

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-27072020-00002
Subject	Conditional Offtake and Purchase Agreement entered into between Nexgram Biomedic Sdn Bhd (NBSB) with PT Mitra Abadi Propertindo Utama (MAPU) for Distributing Personal Protection Equipment to Indonesia (Agreement)
Description	NEXGRAM HOLDINGS BERHAD (NEXGRAM OR THE COMPANY) CONDITIONAL OFFTAKE AND PURCHASE AGREEMENT ENTERED INTO BETWEEN NEXGRAM BIOMEDIC SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING PERSONAL PROTECTION EQUIPMENT TO INDONESIA
Query Letter Contents	We refer to your Company’s announcement dated 23 July 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- The source of the supply of the PPE i.e. the gown and medical gloves to NBSB for NBSB’s onward distribution to MAPU; Total capital and/or investment outlay required of NEXGRAM and/or NBSB in respect of the venture into the distribution of PPE to MAPU; Clarification on whether the sale of PPE to MAPU requires any government approvals in Malaysia and/or Indonesia. If yes, please state the government approvals NSSB needs to obtain and the status of such approvals; and The commencement and expiry dates of the sale of the Products to MAPU as stipulated in the Agreement.
The Company’s announcement dated 23 July 2020 (“Announcement”) and the query letter from Bursa Malaysia Securities Berhad dated 27 July 2020 (Ref : IQL-27072020-00002) in relation to the Conditional Offtake and Purchase Agreement (“Agreement”) refer.  Unless otherwise stated, the terms used in this announcement shall have the same meaning as defined in the Announcement. Please refer to the attached file for the additional information required. This announcement is dated 28 July 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3072561

Attachments Nexgram - Reply Query - COPA.pdf

icy97

NEXGRAM HOLDINGS BERHAD

Particulars of substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	27 Jul 2020	40,000,000	Disposed	Direct Interest
	Name of registered holder	OZURA FIRSTLOGIX SDN BHD
	Address of registered holder	1-47, Jalan SP2 Taman Segar Perdana 43200 Cheras Selangor
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of Shares
Nature of interest	Direct Interest
Direct (units)	218,500,000
Direct (%)	9.263
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	218,500,000
Date of notice	30 Jul 2020
Date notice received by Listed Issuer	30 Jul 2020

icy97

NEXGRAM HOLDINGS BERHAD

Particulars of substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	29 Jul 2020	45,000,000	Disposed	Direct Interest
	Name of registered holder	OZURA FIRSTLOGIX SDN BHD
	Address of registered holder	1-47, Jalan SP2 Taman Segar Perdana 43200 Cheras Selangor
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of Shares
Nature of interest	Direct Interest
Direct (units)	162,000,000
Direct (%)	6.868
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	162,000,000
Date of notice	04 Aug 2020
Date notice received by Listed Issuer	04 Aug 2020

icy97

Notice of Person Ceasing (Section 139 of CA 2016)

NEXGRAM HOLDINGS BERHAD

Particulars of Substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name of registered holder	OZURA FIRSTLOGIX SDN BHD
Address of registered holder	1-47, Jalan SP2Taman Segar Perdana43200 CherasSelangor
Date of cessation	04 Aug 2020

No of securities disposed	43,500,000
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of shares
Nature of interest	Direct Interest
Date of notice	07 Aug 2020
Date notice received by Listed Issuer	07 Aug 2020

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	NEXGRAM HOLDINGS BERHAD  ("NEXGRAM OR COMPANY")MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN NMED INDUSTRIES SDN BHD ("NMEDI"), A WHOLLY OWNED SUB-SUBSIDIARY OF NEXGRAM WITH ARITA HOLDINGS SDN BHD ("AHSB") ("PARTIES")
The Board of Directors of NEXGRAM is pleased to announce that NMEDI had on 12 August 2020 entered into a MOU with AHSB with intention to enter into a definitive sale and purchase agreement (“SPA”) for the Proposed Acquisition of Arita Plastics Indusries (M) Sdn Bhd (“APIMSB”). Please refer to the attachment for details of the announcement. This announcement is dated 13 August 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3077373

Attachments Nexgram - MOU Proposed Acquisition Arita.pdf

icy97

NEXGRAM HOLDINGS BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Conversion of Preference Shares
Details of corporate proposal	Conversion of Irredeemable Convertible Preference Shares ("ICPS") to Ordinary Shares
No. of shares issued under this corporate proposal	300,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0200
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	2,661,204,480
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 230,074,587.650
Listing Date	17 Aug 2020

icy97

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")JOINT VENTURE AGREEMENT ("JVA") BETWEEN INTRA BINARAYA SDN BHD ("IBSB"), A WHOLLY OWNED SUBSIDIARY OF NEXGRAM WITH FALDZE HOLDINGS SDN BHD ("FHSB") ("PARTIES")
The Board of Directors of NEXGRAM is pleased to announce that IBSB had on 14 August 2020 entered into an unincorporated JVA with FHSB, a mutually beneficial relationship with the purpose of administrating, procuring, constructing, providing project funding and establishing strategic partnership pertaining to Central Spine Road Pakej 3: Gua Musang, Kelantan ke Kg Relong, Pahang Seksyen 3D: Bulatan Gua Musang ke Mentara (hereinafter referred to as “the said Project”). The said Project was awarded by Pembinaan Jaya Zira Sdn Bhd (“PJZSB”) to FHSB on 2 July 2020 for a contract sum of RM145 million. Please refer to the attachment for details of the announcement. This announcement is dated 17 August 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3078287

Attachments Nexgram - JVA with FHSB.pdf

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

NEXGRAM HOLDINGS BERHAD

Particulars of Substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name of registered holder	OZURA FIRSTLOGIX SDN BHD
Address of registered holder	1-47, Jalan SP2Taman Segar Perdana43200 CherasSelangor

Date interest acquired & no of securities acquired
Date interest acquired	17 Aug 2020
No of securities	300,000,000
Circumstances by reason of which Securities Holder has interest	Conversion of Irredeemable Convertible Preference Shares
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	309,988,700
Direct (%)	11.659
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	21 Aug 2020
Date notice received by Listed Issuer	21 Aug 2020

icy97

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN TRI-G TECHNOLOGIES SDN BHD ("TRI-G"), A 51% OWNED SUB-SUBSIDIARY OF NEXGRAM AND MALAYSIA TOURISM COUNCIL ("MTC") ("PARTIES")
The Board of Directors of NEXGRAM is pleased to announce that TRI-G, a sub-subsidiary of Nexgram had on 23 July 2020 entered into a MOU with MTC in relation to MTC acquiring services on behalf of its members to obtain medical test kits and its related supplies for Covid-19 Test Solution from TRI-G. Please refer to the attachment for details of the announcement. This announcement is dated 25 August 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3080969

Attachments Nexgram - TRI-G MOU with MTC.pdf

icy97

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-17082020-00001
Subject	Memorandum of understanding ("MOU") between NMED Industries Sdn Bhd ("NMEDI"), a wholly owned sub-subsidiary of Nexgram Holdings Berhad (Nexgram) with Arita Holdings Sdn Bhd ("AHSB") ("Parties") with the intention to enter into a definitive sale and purchase agreement for the proposed acquisition of Arita Plastics Industries (M) Sdn Bhd (APIMSB)(Proposed Acquisition) (MOU)
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN NMED INDUSTRIES SDN BHD ("NMEDI"), A WHOLLY OWNED SUB-SUBSIDIARY OF NEXGRAM HOLDINGS BERHAD ("NEXGRAM") WITH ARITA HOLDINGS SDN BHD ("AHSB") ("PARTIES") WITH THE INTENTION TO ENTER INTO A DEFINITIVE SALE AND PURCHASE AGREEMENT FOR THE PROPOSED ACQUISITION OF ARITA PLASTICS INDUSTRIES (M) SDN BHD ("APIMSB")("PROPOSED ACQUISITION") ("MOU")
Query Letter Contents	We refer to your Company’s announcement dated 13 August 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- To quantify the percentage of shareholdings in APIMSB to be acquired pursuant to the Proposed Acquisition. The date APIMSB commenced its operations. Principal markets for APIMSB’s products. Net profits and net assets of APIMSB based on its latest audited accounts. The total consideration for the Proposed Acquisition, together with –           a) the basis of arriving at the consideration, other than on a “willing buyer willing seller” basis. If it was based on                net assets, the year the net assets were taken into consideration, quantifying the net assets and stating                          whether it was based on audited financial statements; and           b) the justification for the consideration.      6.  Mode of satisfaction of the purchase consideration. Where the purchase consideration is to be satisfied by                    cash, the source of funding and its breakdown. Where the consideration is to be satisfied in whole or in part by              an issue of securities of Nexgram –           i)  the number and type of securities to be issued;           ii) the ranking of the securities;           iii) whether listing will be sought for the securities; and           iv)The issue price, basis of determining the issue price and justification for the pricing of the securities.    7. Where the purchase consideration is to be satisfied in whole or in part by way of transfer of treasury shares, the            information as set out in Part B of Appendix 12C (if applicable);    8. Particulars of all liabilities, including contingent liabilities and guarantees to be assumed by the Nexgram, arising           from the Proposed Acquisition.
The Company’s announcement dated 13 August 2020 (“Announcement”) and the query letter from Bursa Malaysia Securities Berhad dated 17 August 2020 (Ref : IQL-17082020-00001) in relation to the Memorandum of Understanding (“MOU”) refer.  Unless otherwise stated, the terms used in this announcement shall have the same meaning as defined in the Announcement. Please refer to the attached file for the additional information required. This announcement is dated 26 August 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3081782.

Attachments Nexgram - Reply Query MOU with Arita.pdf

icy97

NEXGRAM HOLDINGS BERHAD

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-18082020-00005
Subject	Joint venture agreement (JVA) between Intra Binaraya Sdn Bhd (IBSB), a wholly-owned subsidiary of Nexgram Holdings Berhad with Faldze Holdings Sdn Bhd (FHSB)
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")JOINT VENTURE AGREEMENT ("JVA") BETWEEN INTRA BINARAYA SDN BHD ("IBSB"), A WHOLLY OWNED SUBSIDIARY OF NEXGRAM WITH FALDZE HOLDINGS SDN BHD ("FHSB") ("PARTIES")
Query Letter Contents	We refer to your Company’s announcement dated 17 August 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- The amount of funding required to be provided by IBSB under the JVA,  sources of funding, and the breakdown.
The Company’s announcement dated 17 August 2020 (“Announcement”) and the query letter from Bursa Malaysia Securities Berhad dated 19 August 2020 (Ref : IQL-18082020-00005) in relation to the Joint Venture Agreement (“JVA”) refer.  Unless otherwise stated, the terms used in this announcement shall have the same meaning as defined in the Announcement. The amount of funding required to be provided by IBSB under the JVA, sources of funding, and the breakdown. The amount of funding required to be provided by IBSB under the JVA is amounted to RM5 million which will be funded by internally generated funds and borrowings. The breakdown of the funding will only be made available in due course.  Any development will be updated accordingly. This announcement is dated 28 August 2020.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jul 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jul 2020	31 Jul 2019	31 Jul 2020	31 Jul 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	15,839	15,730	41,277	58,056
2	Profit/(loss) before tax	-59,974	-20,646	-62,264	-19,327
3	Profit/(loss) for the period	-59,068	-22,251	-61,469	-20,893
4	Profit/(loss) attributable to ordinary equity holders of the parent	-59,568	-22,084	-61,890	-21,010
5	Basic earnings/(loss) per share (Subunit)	-2.24	-1.09	-2.33	-1.04
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0342		0.0605

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")ACQUISITION OF 65% OF EQUITY IN ARITA HOLDINGS SDN BHD ("AHSB") BY NMED INDUSTRIES SDN BHD, A SUB-SUBSIDIARY OF THE COMPANY ("PROPOSED ACQUISITION")
Pursuant to Rule 10.05 of the Bursa Malaysia Securities Berhad ACE Market Listing  Requirements, the Board of Directors of Nexgram wishes to announce that NMED Industries Sdn Bhd. (“NMEDI”), a wholly-owned sub-subsidiary of the Company has on 13 October 2020 entered into a Share Sales Agreement (“SSA”) with the following Parties, to obtain a combined total of 65% equity interest in Arita Holdings Sdn Bhd (“AHSB”) (Company No. 210905-P) for a total consideration of Ringgit Malaysia Nineteen Million and Five Hundred Thousand (RM19,500,000.00) only (“the Acquisition”) via the issuance of Redeemable Convertible Preference Shares (“RCPS”) in NMEDI Please refer to the attachment for details of the announcement. This announcement is dated 14 October 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3096275

Attachments SSA Proposed Acquisition AHSB.pdf

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-19102020-00001
Subject	PROPOSED ACQUISITION OF 65% OF EQUITY IN ARITA HOLDINGS SDN BHD ("AHSB") BY NMED INDUSTRIES SDN BHD ("NMEDI"), A SUB-SUBSIDIARY OF THE COMPANY FOR A TOTAL CONSIDERATION OF RM19,500,000.00 ONLY VIA THE ISSUANCE OF REDEEMABLE CONVERTIBLE PREFERENCE SHARES (RCPS) ("PROPOSED ACQUISITION")
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")ACQUISITION OF 65% OF EQUITY IN ARITA HOLDINGS SDN BHD ("AHSB") BY NMED INDUSTRIES SDN BHD, A SUB-SUBSIDIARY OF THE COMPANY ("PROPOSED ACQUISITION")
Query Letter Contents	We refer to your Company’s announcement dated 14 October 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- The names of Elite Plastic Ventures Sdn Bhd's directors and substantial shareholders together with their respective direct and/or indirect shareholdings. Net profits and net assets of AHSB based on its latest audited accounts. The basis of determining the issue price of the RCPS in NMEDI at RM19.50 per RCPS and justification. The ranking of the new NMEDI shares arising from the RCPS conversion. Particulars of all liabilities, including contingent liabilities and guarantees to be assumed by the Nexgram/NMEDI, arising from the Proposed Acquisition. Whether the Proposed Acquisition is subject to the approval of the  shareholders and the relevant government authorities. In the case of approval from the relevant government authorities, the estimated time frame for submission of the application to such authorities. The estimated time frame to complete the Proposed Acquisition. The risks in relation to the Proposed Acquisition. The prospects of AHSB.
The Company’s announcement dated 14 October 2020 (“Announcement”) and the query letter from Bursa Malaysia Securities Berhad dated 19 October 2020 (Ref : IQL-19102020-00001) in relation to the Proposed Acquisition refer.  Unless otherwise stated, the terms used in this announcement shall have the same meaning as defined in the Announcement. Please refer to the attached file for the additional information required. Please refer to the attachment for details of the announcement. This announcement is dated 22 October 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3098563

Attachments Nexgram - Reply Query - SSA Arita.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")PRESS RELEASE : NEXGRAM INKED LETTER OF ACCEPTANCE BY NATIONAL SECURITY COUNCIL ("MKN") TO USE TRACVIRUS ELECTRONIC HEALTH CHECK SYSTEM FOR INBOUND TRAVELLERS FOR MINISTRY OF HEALTH ("MOH")
The Board of Directors of NEXGRAM is pleased to announce that Nexgram had on 23 July 2020 secured MKN acceptance for the use of Covid-19 electronic health check system (known as "Tracvirus") for all nationwide borders, including inbound and outbound traverllers. Tracvirus developed by Medic Data Science Ltd, and distributed by Tri-G Technologies Sdn. Bhd., both are subsidiaries of Nexgram. Please refer to the attachment in relation to the press release for further details. This announcement is dated 6 November 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3103153

Attachments Nexgram - MKN TRACVIRUS COVID19 INBOUND TRAVEL E-CERT press release.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "THE COMPANY") PANEL GOVERNMENT SYSTEM INTEGRATOR CONTRACT ("PGSIC") ENTERED INTO BETWEEN TRI-G TECHNOLOGIES SDN BHD AND VACCINES LAB SDN BHD WITH OTTIGO SDN BHD FOR GOVERNMENT LINKED CORPORATION ("GLC") PANEL SYSTEMS INTEGRATOR FOR COVID-19 "TRACVIRUS SAFETRAVELPASS" BY MINISTRY OF HEALTH ("MOH") FOR ALL INBOUND AND OUTBOUND TRAVELERS COVID-19 SCREENING AND QUARANTINE ACCOMODATION
The Board of Directors of Nexgram is pleased to announce that Tri-G Technologies Sdn Bhd. (“TRI-G”), a 51% owned sub-subsidiary and Vaccines Lab Sdn Bhd (“VaccinesLab”), a wholly-owned sub-subsidiary of the Company has on 11 November 2020 entered into a Panel Government System Integrator Contract (“PGSIC” or “Contract”) with Ottigo Sdn Bhd (“OTTIGO”) (collectively referred to “the Party” or “the Parties”) to operate for Government Linked Corporation (“GLC”) panel systems integrator for Covid-19 "Tracvirus SafeTravelPass" by Ministry of Health (“MOH”) for all inbound and outbound travellers Covid-19 Screening and Quarantine Accommodation (“the Contract”) for a period of twenty-four (24) months. Please refer to the attachment in relation to the press release for further details. This announcement is dated 12 November 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3104711

Attachments Nexgram - Award PGSIC to Ottigo - final 2.pdf Nexgram - Press Released Awarded Ottigo - final 3.pdf

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")MASTER STRATEGIC JOINT VENTURE AGREEMENT BETWEEN VACCINES LAB SDN BHD ("VACCINESLAB"), A WHOLLY OWNED SUBSIDIARY OF NEXGRAM WITH RAFARMA PHARMACEUTICALS INC. ("RAFARMA") ("PARTIES")
The Board of Directors of NEXGRAM is pleased to announce that VACCINESLAB had on 3 December 2020 entered into a Master Strategic Joint Venture Agreement (“MSJVA”) with RAFARMA, for the purpose to developing cooperation in the distribution, supply, license and rights, OEM and manufacturing plant dedicated to vaccines solely or jointly development by RAFARMA. VACCINESLAB and RAFARMA desire to jointly develop and conduct initial clinical trial and expanded clinical trial (“Clinical Trial”) and invest in LARGE-SCALE COVID-19 VACCINE FACILITY IN INDONESIA (“Vaccine Plant”) exclusively for the above and other various vaccines as well as other immunological promising drug, use developed by RAFARMA, especially clinical trials in regional trial sites outside of USA and China with this MSJVA. Please refer to the attachment for details of the announcement. This announcement is dated 10 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3112948

Attachments Nexgram - JVA with RAFARMA.pdf

Notice of Person Ceasing (Section 139 of CA 2016)

NEXGRAM HOLDINGS BERHAD

Particulars of Substantial Securities Holder

Name	OZURA FIRSTLOGIX SDN BHD
Address	1-47, Jalan SP2 Taman Segar Perdana Cheras 43200 Selangor Malaysia.
Company No.	877960-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name of registered holder	OZURA FIRSTLOGIX SDN BHD
Address of registered holder	1-47, Jalan SP2Taman Segar Perdana43200 CherasSelangor
Date of cessation	10 Dec 2020

No of securities disposed	46,000,000
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of Shares
Nature of interest	Direct Interest
Date of notice	11 Dec 2020
Date notice received by Listed Issuer	11 Dec 2020

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-14122020-00001
Subject	Master strategic joint venture agreement between Vaccines Lab Sdn Bhd (VaccinesLab), a wholly-owned subsidiary of Nexgram Holdings Berhad, with Rafarma Pharmaceuticals Inc. (RAFARMA)
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "THE COMPANY") MASTER STRATEGIC JOINT VENTURE AGREEMENT BETWEEN VACCINES LAB SDN BHD ("VACCINESLAB"), A WHOLLY-OWNED SUBSIDIARY OF NEXGRAM HOLDINGS BERHAD, WITH RAFARMA PHARMACEUTICALS INC. ("RAFARMA")
Query Letter Contents	We refer to your Company’s announcement dated 10 December 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- The proposed principal activities of the joint venture company (“JVC”); The capital and investment outlay by VaccinesLab in the JVC, its sources of funding and the breakdown; The relevant regulatory approvals required to be obtained by the JVC before it can commence  its operations; The equity interest to be subscribed by VaccineLabs in the JVC; Please provide further information on RAFARMA including the shareholders, board of directors, senior management, and the listing status (if RAFARMA is listed); Pertaining to the Parties’ desire to develop and conduct the Clinical Trial and invest in the Vaccine Plant, please clarify how does RAFARMA intend to strive for access to the Covid-19 vaccines for use / test / distribution, i.e. whether RAFARMA intends to source for the said vaccine or intends to develop the said vaccine. To also clarify the current stage of acquisition / development of the Covid-19 vaccines; Please clarify what are the expected or agreed milestones with regard to Clinical Trial and Vaccine Plant; Please clarify the source of funding and/or arrangement through which RAFARMA intends to secure the USD 1 billion investment; Paragraph 4.3 of the announcement states that VaccineLabs will provide government joint venture, partnership, regulation, licenses, and initiatives for the project. Please clarify if NEXGRAM and/or VaccineLabs has secured any agreements with any government with regard to the joint venture with RAFARMA.  If yes, please provide details of these agreements and the government parties involved; and Please clarify on the agreed structure of JVC in terms of the management and board of directors’ structure.
The Company’s announcement dated 10 December 2020 (“Announcement”) and the query letter from Bursa Malaysia Securities Berhad dated 14 December 2020 (Ref : IQL-14122020-00001) in relation to the Master Strategic Joint Venture Agreement (“Agreement”) refer.  Unless otherwise stated, the terms used in this announcement shall have the same meaning as defined in the Announcement. Please refer to the attached file for the additional information required. This announcement is dated 15 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3113971

Attachments Nexgram - Reply Query JVA with Rafarma.pdf

SUMMARY OF KEY FINANCIAL INFORMATION 31 Oct 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Oct 2020	31 Oct 2019	31 Oct 2020	31 Oct 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	12,946	12,003	12,946	12,003
2	Profit/(loss) before tax	-2,838	477	-2,838	477
3	Profit/(loss) for the period	-2,814	500	-2,814	500
4	Profit/(loss) attributable to ordinary equity holders of the parent	-2,665	67	-2,665	67
5	Basic earnings/(loss) per share (Subunit)	-0.12	0.00	-0.12	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0488		0.0428

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")CHINA PANEL GOVERNMENT SYSTEM INTEGRATOR CONTRACT ("CHINA-PGSIC") ENTERED INTO BETWEEN TRI-G TECHNOLOGIES SDN BHD AND VACCINES LAB SDN BHD WITH WAN SHENG KE ADVISORY SERVICE SHENZHEN LIMITED TO FACILITATE ALL CHINA FOREIGN STUDENTS AND TRAVELLERS FOR ONE STOP PAYMENT PORTAL FOR THE APPLICATION OF SAFETRAVELPASS ("STP")
The Board of Directors of Nexgram is pleased to announce that Tri-G Technologies Sdn Bhd. (“TRI-G”), a 51% owned sub-subsidiary and Vaccines Lab Sdn Bhd (“VACCINESLAB”), a wholly-owned sub-subsidiary of the Company had on 31 December 2020 entered into a China Panel Government System Integrator Contract (“China-PGSIC” or “Contract”) with Wan Sheng Ke Advisory Service Shenzhen Limited (“WANSHENGKE”) (collectively referred to “the Party” or “the Parties”), dedicated to facilitate all China foreign students and travellers from China a one stop payment portal for the application of SafeTravelPass (“STP”), to facilitate the Covid-19 Screening Test, Vaccine Check, Quarantine, Accommodation, Immigration Department’s MyTravelPass and E-Visa verification, trial run effective 1st January 2021, in conjunction with the government’s announcement on accepting foreign students on the same date. Please refer to the attachment for details of the announcement. This announcement is dated 7 January 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119438

Attachments Nexgram - China-PGSIC with WANSHENGKE.pdf

Type	Announcement
Subject	OTHERS
Description	NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "COMPANY")SOUTH KOREA PANEL GOVERNMENT SYSTEM INTEGRATOR CONTRACT ("SOUTHKOREA-PGSIC") ENTERED INTO BETWEEN TRI-G TECHNOLOGIES SDN BHD AND VACCINES LAB SDN BHD WITH KOCO STAGE CO. INC. TO DEDICATED FOR ALL COVID-19 ONLY BUSINESS RELATED TO SOUTH KOREA GOVERNMENT INTEGRATION
The Board of Directors of Nexgram is pleased to announce that Tri-G Technologies Sdn Bhd. (“TRI-G”), a 51% owned sub-subsidiary and Vaccines Lab Sdn Bhd (“VACCINESLAB”), a wholly-owned sub-subsidiary of the Company had on 7 January 2021 entered into a South Korea Panel Government System Integrator Contract (“SOUTHKOREA-PGSIC” or “Contract”) with Koco Stage Co. Inc. (“KOCO”) (collectively referred to “the Party” or “the Parties”), dedicated for all “Covid-19” only business relating to South Korea government integration, including but not limited to South Korea National Security Administration, National Disaster & Emergency Administration, Foreign Affair Ministry, Immigration, Health Ministry, relevant government agencies, and airport, port and borders control etc, and airport inbound and outbound control, and government labs; and non-exclusive in other technology cooperation. Please refer to the attachment for details of the announcement. This announcement is dated 8 January 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119917

Attachments Nexgram - South Korea PGSIC with KOCO.pdf

NEXGRAM HOLDINGS BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Conversion of Preference Shares
Details of corporate proposal	Conversion of Irredeemable Convertible Preference Shares ("ICPS") to Ordinary Shares
No. of shares issued under this corporate proposal	80,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0200
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	2,741,204,480
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 230,874,587.650
Listing Date	26 Jan 2021

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Jul 2021

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Jul 2021	31 Jul 2020	31 Jul 2021	31 Jul 2020
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,120	15,839	75,077	41,142
2	Profit/(loss) before tax	-1,722	-59,974	-4,350	-63,320
3	Profit/(loss) for the period	-2,376	-59,068	-4,985	-62,824
4	Profit/(loss) attributable to ordinary equity holders of the parent	-2,531	-59,568	-5,060	-61,891
5	Basic earnings/(loss) per share (Subunit)	-0.07	-2.67	-0.14	-2.77
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0310		0.0428

icy97

NEXGRAM HOLDINGS BERHAD

Particulars of substantial Securities Holder

Name	TUAN HAJI MAZRU BIN MAT YUSOF
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	11 Oct 2021	200,000,000	Disposed	Direct Interest
	Name of registered holder	Haji Mazru bin Mat Yusof
	Description of "Others" Type of Transaction
2	11 Oct 2021	200,000,000	Acquired	Indirect Interest
	Name of registered holder	EMEMY Resources Sdn Bhd
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal and acquisition of shares via off market transaction
Nature of interest	Direct and Indirect Interest
Direct (units)	611,087,071
Direct (%)	13.844
Indirect/deemed interest (units)	400,000,000
Indirect/deemed interest (%)	9.062
Total no of securities after change	1,011,087,071
Date of notice	12 Oct 2021
Date notice received by Listed Issuer	12 Oct 2021

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

NEXGRAM HOLDINGS BERHAD

Particulars of Substantial Securities Holder

Name	EMEMY RESOURCES SDN BHD
Address	Level 2, Tower 1, Avenue 5, Bangsar South City Kuala Lumpur 59200 Wilayah Persekutuan Malaysia.
Company No.	1418558-K
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name of registered holder	EMEMY RESOURCES SDN BHD
Address of registered holder	Level 2, Tower 1, Avenue 5, Bangsar South City

Date interest acquired & no of securities acquired
Date interest acquired	11 Oct 2021
No of securities	200,000,000
Circumstances by reason of which Securities Holder has interest	Acquisition of Shares via off market transaction
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	400,000,000
Direct (%)	9.062
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	13 Oct 2021
Date notice received by Listed Issuer	13 Oct 2021

icy97

NEXGRAM HOLDINGS BERHAD

Particulars of substantial Securities Holder

Name	EMEMY RESOURCES SDN BHD
Address	Level 2, Tower 1, Avenue 5, Bangsar South City Kuala Lumpur 59200 Wilayah Persekutuan Malaysia.
Company No.	1418558-K
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	21 Oct 2021	157,400,000	Acquired	Indirect Interest
	Name of registered holder	EMEMY Resources Sdn Bhd
	Address of registered holder	Level 2, Tower 1, Avenue 5 Bangsar South City 59200 Kuala Lumpur
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquisition of shares via off market transaction
Nature of interest	Direct Interest
Direct (units)	557,400,000
Direct (%)	12.627
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	557,400,000
Date of notice	22 Oct 2021
Date notice received by Listed Issuer	22 Oct 2021